These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37344761)

  • 1. Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
    Yu B; Ma SJ; Khan M; Gill J; Iovoli A; Fekrmandi F; Farrugia MK; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky EA; Singh AK
    BMC Cancer; 2023 Jun; 23(1):572. PubMed ID: 37344761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Optimal Threshold of Neutrophil-Lymphocyte Ratio and Its Association With Survival Outcomes Among Patients With Head and Neck Cancer.
    Ma SJ; Yu H; Khan M; Gill J; Santhosh S; Chatterjee U; Iovoli A; Farrugia M; Mohammadpour H; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Hicks WL; Platek ME; Seshadri M; Ray AD; Repasky E; Singh AK
    JAMA Netw Open; 2022 Apr; 5(4):e227567. PubMed ID: 35426920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
    Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
    Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of lymphocyte to monocyte ratio in the prognosis of head and neck squamous cell carcinoma: a meta-analysis.
    Wei D; Liu J; Ma J
    PeerJ; 2023; 11():e16014. PubMed ID: 37719125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiation.
    Ma SJ; Yu H; Khan M; Yu B; Santhosh S; Chatterjee U; Gill J; Iovoli A; Farrugia M; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Platek ME; Seshadri M; Ray AD; Repasky E; Singh AK
    Oral Oncol; 2022 Oct; 133():106054. PubMed ID: 35933937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis.
    Nishijima TF; Muss HB; Shachar SS; Tamura K; Takamatsu Y
    Cancer Treat Rev; 2015 Dec; 41(10):971-8. PubMed ID: 26481060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of low adherence to weekly cisplatin with outcomes in patients with head and neck squamous cell carcinoma: a retrospective cohort study.
    Virk J; Gill J; Fekrmandi F; Iovoli A; Farrugia M; Al-Afif A; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Hicks WL; Ma SJ; Singh AK
    BMC Cancer; 2024 Jul; 24(1):838. PubMed ID: 39003442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis.
    Tham T; Wotman M; Chung C; Ahn S; Dupuis H; Gliagias V; Movsesova T; Kraus D; Costantino P
    Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2913-2922. PubMed ID: 31312922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck Cancer.
    Ma SJ; Yu H; Yu B; Waldman O; Khan M; Chatterjee U; Santhosh S; Gill J; Iovoli AJ; Farrugia M; Shevorykin A; Carl E; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Platek ME; Seshadri M; Sheffer C; Warren GW; Singh AK
    JAMA Netw Open; 2022 Dec; 5(12):e2245818. PubMed ID: 36480200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
    Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
    Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of preoperative lymphocyte-to-monocyte ratio on survival outcomes in bladder cancer patients after radical cystectomy.
    Bi H; Yan Y; Wang D; Qin Z; Wang G; Ma L; Huang Y; Lu J
    J Cancer; 2021; 12(2):305-315. PubMed ID: 33391427
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma.
    Yamagishi T; Fujimoto N; Nishi H; Miyamoto Y; Hara N; Asano M; Fuchimoto Y; Wada S; Kitamura K; Ozaki S; Kishimoto T
    Lung Cancer; 2015 Oct; 90(1):111-7. PubMed ID: 26259877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent Comparison of the Prognostic Values of Tumor Budding, Tumor Stroma Ratio, Tumor Infiltrating Pattern and Lymphocyte-to-Monocyte Ratio in Colorectal Cancer Patients.
    Zhang Y; Liu Y; Qiu X; Yan B
    Technol Cancer Res Treat; 2021; 20():15330338211045826. PubMed ID: 34658263
    [No Abstract]   [Full Text] [Related]  

  • 14. The prognostic role of lymphocyte to monocyte ratio (LMR) in patients with Myelodysplastic Neoplasms.
    Lu C; Chen Q; Li J; Wang C; Yu L
    Hematology; 2023 Dec; 28(1):2210929. PubMed ID: 37166128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
    Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
    Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort study.
    Lin CH; Chou WC; Wu YY; Lin CY; Chang KP; Liao CT; Ho TY; Yeh CM; Liu CJ; Hung SP; Lee CH; Chen PJ; Chou YC; Fan KH; Huang BS; Tung-Chieh Chang J; Wang CC; Tsang NM
    Radiother Oncol; 2021 Jan; 154():76-86. PubMed ID: 32941957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.
    Li J; Jiang R; Liu WS; Liu Q; Xu M; Feng QS; Chen LZ; Bei JX; Chen MY; Zeng YX
    PLoS One; 2013; 8(12):e83069. PubMed ID: 24386144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy.
    Zhao K; Wang C; Shi F; Huang Y; Ma L; Li M; Song Y
    BMC Cancer; 2021 Jan; 21(1):66. PubMed ID: 33446134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma.
    Gu L; Ma X; Xie Y; Li H; Wang L; Chen L; Zhao W; Zhang Y; Zhang X
    Clin Genitourin Cancer; 2017 Jun; 15(3):e369-e377. PubMed ID: 28038932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.